Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine.
作者信息
SMITHBURN K C
出版信息
Br J Exp Pathol. 1949 Feb;30(1):1-16.
Abstract
摘要
相似文献
1
Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine.
Br J Exp Pathol. 1949 Feb;30(1):1-16.
2
Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
Virus Res. 2016 May 2;216:55-65. doi: 10.1016/j.virusres.2015.05.012. Epub 2015 May 27.
3
Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
Expert Rev Vaccines. 2017 Jun;16(6):601-611. doi: 10.1080/14760584.2017.1321482. Epub 2017 May 2.
4
[Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
Wei Sheng Wu Xue Bao. 2007 Aug;47(4):677-81.
5
6
Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe.
Vaccine. 2015 Oct 13;33(42):5520-5531. doi: 10.1016/j.vaccine.2015.08.020. Epub 2015 Aug 19.
7
Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
Antiviral Res. 2014 Aug;108:165-72. doi: 10.1016/j.antiviral.2014.05.020. Epub 2014 Jun 14.
8
Experimental Infection of Calves by Two Genetically-Distinct Strains of Rift Valley Fever Virus.
Viruses. 2016 May 23;8(5):145. doi: 10.3390/v8050145.
9
Comparative efficacy of two next-generation Rift Valley fever vaccines.
Vaccine. 2014 Sep 3;32(39):4901-8. doi: 10.1016/j.vaccine.2014.07.037. Epub 2014 Jul 19.
10
Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
J Virol. 2015 Jul;89(14):7262-76. doi: 10.1128/JVI.00135-15. Epub 2015 May 6.
引用本文的文献
1
Rift Valley fever seroprevalence and risk factors among human populations in Uganda's cattle corridor: a cross-sectional study.
BMJ Public Health. 2025 Jul 31;3(2):e002563. doi: 10.1136/bmjph-2025-002563. eCollection 2025.
2
The Temperature-Associated Effects of Rift Valley Fever Virus Infections in Mosquitoes and Climate-Driven Epidemics: A Review.
Viruses. 2025 Feb 1;17(2):217. doi: 10.3390/v17020217.
3
Pasteurization temperatures effectively inactivate Rift Valley fever viruses in milk.
J Virol. 2025 Feb 25;99(2):e0202624. doi: 10.1128/jvi.02026-24. Epub 2025 Jan 30.
4
Mosquito-independent milk-associated transmission of zoonotic Wesselsbron virus in sheep.
PLoS Pathog. 2024 Dec 9;20(12):e1012751. doi: 10.1371/journal.ppat.1012751. eCollection 2024 Dec.
5
Laboratory Animal Models for Rift Valley Fever Virus Disease.
Methods Mol Biol. 2024;2824:425-445. doi: 10.1007/978-1-0716-3926-9_27.
6
Vaccine strains of Rift Valley fever virus exhibit attenuation at the maternal-fetal placental interface.
J Virol. 2024 Aug 20;98(8):e0098324. doi: 10.1128/jvi.00983-24. Epub 2024 Jul 17.
7
Vaccine strains of Rift Valley fever virus exhibit attenuation at the maternal-fetal placental interface.
bioRxiv. 2024 Jun 1:2024.05.31.596800. doi: 10.1101/2024.05.31.596800.
8
Rift Valley Fever Virus Encephalitis: Viral and Host Determinants of Pathogenesis.
Annu Rev Virol. 2024 Sep;11(1):309-325. doi: 10.1146/annurev-virology-093022-011544. Epub 2024 Aug 30.
9
Advancements in Rift Valley fever vaccines: a historical overview and prospects for next generation candidates.
NPJ Vaccines. 2023 Nov 4;8(1):171. doi: 10.1038/s41541-023-00769-w.
10
Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep.
Virol J. 2023 Oct 3;20(1):221. doi: 10.1186/s12985-023-02180-2.
Zotero 插件